Aerpio Pharmaceuticals Current Cash

Aerpio Pharmaceuticals (ARPO) currently reports a current cash of $35M as of March 2026. That compares with $230M in the prior-year period — down 84.7% year over year. Use the charts on this page to explore Aerpio Pharmaceuticals's current cash history and peer comparisons.

Aerpio Pharmaceuticals's current cash decreased from $230M to $35M — a 84.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aerpio Pharmaceuticals reported $35M in current cash as of March 2026. That compares with $230M in the prior-year period — down 84.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aerpio Pharmaceuticals, and consider following ARPO for alerts when major investors trade the stock.

Aerpio Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARPO with unrelated industries.